Your browser doesn't support javascript.
loading
Recurrent mutations of CD79B and MYD88 are the hallmark of primary central nervous system lymphomas.
Nakamura, T; Tateishi, K; Niwa, T; Matsushita, Y; Tamura, K; Kinoshita, M; Tanaka, K; Fukushima, S; Takami, H; Arita, H; Kubo, A; Shuto, T; Ohno, M; Miyakita, Y; Kocialkowski, S; Sasayama, T; Hashimoto, N; Maehara, T; Shibui, S; Ushijima, T; Kawahara, N; Narita, Y; Ichimura, K.
Affiliation
  • Nakamura T; Division of Brain Tumor Translational Research, National Cancer Center Research Institute, Tokyo, Japan.
  • Tateishi K; Department of Neurosurgery, Graduate School of Medicine, Yokohama City University, Yokohama, Japan.
  • Niwa T; Division of Brain Tumor Translational Research, National Cancer Center Research Institute, Tokyo, Japan.
  • Matsushita Y; Department of Neurosurgery, Graduate School of Medicine, Yokohama City University, Yokohama, Japan.
  • Tamura K; Division of Epigenomics, National Cancer Center Research Institute, Tokyo, Japan.
  • Kinoshita M; Department of Neurosurgery and Neuro-oncology, National Cancer Center, Tokyo, Japan.
  • Tanaka K; Department of Neurosurgery, Tokyo Medical and Dental University, Tokyo, Japan.
  • Fukushima S; Department of Neurosurgery, Graduate School of Medicine, Osaka University, Osaka, Japan.
  • Takami H; Department of Neurosurgery, Graduate School of Medicine, Kobe University, Kobe, Japan.
  • Arita H; Division of Brain Tumor Translational Research, National Cancer Center Research Institute, Tokyo, Japan.
  • Kubo A; Division of Brain Tumor Translational Research, National Cancer Center Research Institute, Tokyo, Japan.
  • Shuto T; Department of Neurosurgery and Neuro-oncology, National Cancer Center, Tokyo, Japan.
  • Ohno M; Department of Neurosurgery, Graduate School of Medicine, Osaka University, Osaka, Japan.
  • Miyakita Y; Department of Neurosurgery, Yokosuka Kyosai Hospital, Yokosuka, Japan.
  • Kocialkowski S; Department of Neurosurgery, Yokohama Rosai Hospital, Yokohama, Japan.
  • Sasayama T; Department of Neurosurgery and Neuro-oncology, National Cancer Center, Tokyo, Japan.
  • Hashimoto N; Department of Neurosurgery and Neuro-oncology, National Cancer Center, Tokyo, Japan.
  • Maehara T; Department of Pathology, University of Cambridge, Cambridge, UK.
  • Shibui S; Department of Neurosurgery, Graduate School of Medicine, Kobe University, Kobe, Japan.
  • Ushijima T; Department of Neurosurgery, Graduate School of Medicine, Osaka University, Osaka, Japan.
  • Kawahara N; Department of Neurosurgery, Tokyo Medical and Dental University, Tokyo, Japan.
  • Narita Y; Department of Neurosurgery and Neuro-oncology, National Cancer Center, Tokyo, Japan.
  • Ichimura K; Division of Epigenomics, National Cancer Center Research Institute, Tokyo, Japan.
Neuropathol Appl Neurobiol ; 42(3): 279-90, 2016 Apr.
Article de En | MEDLINE | ID: mdl-26111727
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Lymphome B diffus à grandes cellules / Tumeurs du système nerveux central / Antigènes CD79 / Facteur de différenciation myéloïde-88 Type d'étude: Prognostic_studies / Risk_factors_studies Limites: Aged / Female / Humans / Male / Middle aged Langue: En Journal: Neuropathol Appl Neurobiol Année: 2016 Type de document: Article Pays d'affiliation: Japon
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Lymphome B diffus à grandes cellules / Tumeurs du système nerveux central / Antigènes CD79 / Facteur de différenciation myéloïde-88 Type d'étude: Prognostic_studies / Risk_factors_studies Limites: Aged / Female / Humans / Male / Middle aged Langue: En Journal: Neuropathol Appl Neurobiol Année: 2016 Type de document: Article Pays d'affiliation: Japon